Apexigen, Inc.(NASDAQ:APGN) 
Apexigen Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody therapeutics for oncology. It develops a pipeline of product candidates, including APX005M, a humanized agonist antibody that is in Phase II clinical development for the treatment of solid tumors, such as mela...
Website: https://www.apexigen.com
Founded: 2010
IPO Price: $10 (Jul 29, 2022)
Full Time Employees: 22
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2023-03-07
P
O 0.87
H 0.92
L 0.85
C 0.90
V 140,254
10EMA 0.90
20EMA 0.90
60EMA 0.90
120EMA 0.90
250EMA 0.90